Shrey Modi, MD
Colon & Rectal Surgery · Bettendorf, IANPI 1336671593
Payments from drug & device makers
What this record shows
10 manufacturers reported payments, led by Intuitive Surgical at 51.1% of the total. Reporting peaked in 2023 at $1,616 and has fallen 92.2% since, to $126 in 2025.
Across 20 payments — averaging $135.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Lantheus Medical Imaging, Inc.$290
- Medtronic$173
- Boston Scientific$148
- Davol Inc.$128
- E.r. Squibb & Sons, L.L.C.$125
- plus $456 from 4 others
What the payments were for
- Travel & lodging$1,26747%
- Food & beverage$1,43353%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $1,380 |
| Lantheus Medical Imaging, Inc. | 2 | $290 |
| Medtronic | 3 | $173 |
| Boston Scientific | 1 | $148 |
| Davol Inc. | 2 | $128 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| AstraZeneca | 1 | $125 |
| Akcea Therapeutics, Inc. | 1 | $125 |
| BD | 1 | $106 |
| Olympus Corporation Of The Americas | 1 | $101 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,248
- Definity$290
- Phasix Mesh$217
- WATCHMAN Access System$148
- FARXIGA$125
- TEGSEDI$125
- EVIS EXERA lll COLONOVIDEOSCOPE$101
How this compares
Too few colon & rectal surgery providers in Iowato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 26 | $520 |
| Metronidazole | 39 | $143 |
| Neomycin Sulfate | 26 | $123 |
| Gabapentin | 28 | $105 |
| Oxycodone Hcl | 36 | $72 |
| Methocarbamol | 14 | $58 |
| Tramadol Hcl | 19 | $40 |
| Ondansetron Hcl | 25 | $36 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Bettendorf
- Ohmar CoughlinDes Moines$13K
- Muneera KapadiaIowa City$10K
- Alexander MenningDes Moines$8K
- Mayin LinDes Moines$6K
- Kristina GuytonIowa City$6K
- Michael PageDes Moines$5K
- Jennifer HrabeIowa City$3K
- Daniel OpheimDes Moines$3K
- Molly GrossDes Moines$2K
- Shankar RamanDes Moines$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.